DRDO dismisses Patanjali’s claim on 2DG drug

Patanjali has done nothing much, they did publish a paper but it was based on our study, DRDO said. Gurugram: TheDefense Research and Development Organisation (DRDO) has said that Patanjali had nothing to do with the research of their new drug 2DG. This comes in response to Patanjali Chief Executive Officer (CEO) Acharya Balkrishna’s claim that the newly-launched […]

Continue Reading